Combination therapy with liposomal neuroprotectants and tissue plasminogen activator for treatment of ischemic stroke.
Fukuta T, Asai T, Yanagida Y, Namba M, Koide H, Shimizu K, Oku N.
Fukuta T, et al. Among authors: yanagida y.
FASEB J. 2017 May;31(5):1879-1890. doi: 10.1096/fj.201601209R. Epub 2017 Jan 12.
FASEB J. 2017.
PMID: 28082354
These findings suggest that treatment with fasudil-Lip before tPA could decrease the risk of tPA-derived cerebral hemorrhage and extend the TTW of tPA and that the combination therapy could be a useful therapeutic option for ischemic stroke.-Fukuta, T., Asai, T., Yanagida, …
These findings suggest that treatment with fasudil-Lip before tPA could decrease the risk of tPA-derived cerebral hemorrhage and extend the …